Avantor Inc (AVTR) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Total Revenue Chart for Avantor Inc

Avantor Inc (AVTR) revenue for FY2025 was USD 6.6B, a -3.4% change from FY2024. Avantor Inc's revenue grew from USD 636.9M in 2015 to USD 6.6B in 2025 (928.8% over 10 years). Earnings per share grew from USD 0.04 in 2015 to USD 0.97 in 2022 (2311.3%). Revenue compound annual growth rate: 5-year CAGR of 0.5%, 10-year CAGR of 26.3%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$10.38B
Implied Share Price
$15.35
Enterprise Value
$13.37B
Revenue (TTM)
$6.56B
EBITDA
$943.70M
Profit Margin
-8.81%
Trailing P/E
—
Forward P/E
16.86
Price/Book (MRQ)
1.77
Price/Sales (TTM)
1.58
EV/EBITDA
118.46
EV/Revenue
2.04
Dividend Yield
—
Book Value
$8.32
Free Cash Flow (FY2025)
$495.00M
Free Cash Flow Yield
4.77%

Snapshot as of 8th October 2026 — not point-in-time controlled, may lag the live market by a few days.